Blue Trust Inc. possesses $167,000 in holdings with Align Technology, Inc. (NASDAQ:ALGN).

2 min read | February 05, 2025 12:28 AM PST | By Team Kalkine Media

Highlights

  • Blue Trust Inc. increased its investment in Align Technology (NASDAQ:ALGN) by 41.4% in Q4.
  • Align Technology shares opened at $214.75 with a 52-week range of $196.09 to $335.40.
  • Analyst ratings for Align Technology reveal a moderate buy consensus, with price targets adjusted recently.

Investment Activities

The recent Form 13F filing with the SEC revealed that Blue Trust Inc. elevated its stake in Align Technology, Inc. by 41.4% during the fourth quarter. The firm possessed 803 shares valued at $167,000 by the end of the period, demonstrating increased confidence in the medical equipment provider's prospects.

Other investment firms have shown similar interest in Align Technology. For instance, True Wealth Design LLC expanded its position significantly by 10,700% in the third quarter, while Neo Ivy Capital Management acquired a new stake altogether. CVA Family Office LLC, Mather Group LLC., and Versant Capital Management Inc also increased their holdings substantially during this timeframe.

Market Performance

Shares of Align Technology (NASDAQ:ALGN) began trading at $214.75 on a recent Wednesday. The shares fluctuate within a 52-week range between $196.09 and $335.40. The company holds a market capitalization of $16.03 billion, with a P/E ratio of 36.65 and a price-to-earnings-growth ratio of 4.80, indicating a balanced growth trajectory. The stock's beta stands at 1.67, reflecting its volatility in relation to the broader market trends. Additionally, the 50-day and 200-day simple moving averages are recorded at $222.45 and $226.48, respectively.

About Align Technology

Align Technology, Inc., known for designing and manufacturing Invisalign clear aligners, alongside iTero intraoral scanners, serves orthodontists and dental practitioners globally. The company's product portfolio includes packages geared towards comprehensive orthodontic care for varying age groups, demonstrating their expansive market reach and adaptation to patient needs.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next